Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
CD8-positive T lymphocytes
Email alerts
CD8-positive T lymphocytes
Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy
James
Harber
,
Tamihiro
Kamata
,
Catrin
Pritchard
,
Dean
Fennell
Journal for ImmunoTherapy of Cancer
Sep 2021,
9
(9)
e003032;
DOI:
10.1136/jitc-2021-003032
Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
Hsin-Yu
Liu
,
Christophe
Pedros
,
Kok-Fai
Kong
,
Ann J
Canonigo-Balancio
,
Wen
Xue
,
Amnon
Altman
Journal for ImmunoTherapy of Cancer
Sep 2021,
9
(9)
e002792;
DOI:
10.1136/jitc-2021-002792
Special collections
COVID-19
(44)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(538)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(941)
Commentary/Editorials
(142)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(55)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(213)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(409)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(143)
Reviews
(239)
Open access
(4875)
Press releases
